FORWARD II ASCO Abstract | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49454 of 49496  at  5/15/2019 6:08:30 PM  by

sooner_or_later55


 In response to msg 49452 by  Bibliobiftek
view thread

Re: FORWARD II ASCO Abstract

Correct me if I am wrong but the data in this abstract for the subset analysis of pts (n = 16) who were bevacizumab-nave, had 1-2 prior therapies is identical to the data present in May2018.

http://investor.immunogen.com/static-files/6f3c4aa2-bee7-47ce-908b-9e1f8a82e48d

Are these different patients? Strange to have the same exact outcome.

Sooner


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 211
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
49458 Re: FORWARD II ASCO Abstract Bibliobiftek 2 5/15/2019 8:53:10 PM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...